Linagliptin

Trade Name: 
Trajenta
Manufacturer/Distributor: 
Boehringer Ingelheim
http://www.boehringer-ingelheim.ca
Classification: 
Oral antihyperglycemic agent
DPP-4 inhibitor, Incretin enhancer
ATC Class: 
A10BH05 - Linagliptin
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2011/07/18
Date Marketed in Canada (yyyy/mm/dd): 
2011/09/13
Presentation: 
Tablet: 5 mg. DIN: 023870921
Comments: 
To improve glycemic control in adult patients with type 2 diabetes mellitus.